MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
7.31
-0.24 (-3.18%)
At close: Jun 13, 2025, 4:00 PM
7.61
+0.30 (4.10%)
After-hours: Jun 13, 2025, 4:07 PM EDT
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $28.90 million as of June 13, 2025. Its market cap has decreased by -24.24% in one year.
Market Cap
28.90M
Enterprise Value
30.78M
1-Year Change
-24.24%
Ranking
Category
Stock Price
$7.31
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $28.90M, a decrease of -92.52%. That is a compound annual growth rate of -50.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 28.90M | 4.63% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |
| AstraZeneca | 231.58B |